Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Lymphocytes, Tumor-Infiltrating"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 141
Tytuł:
Lymphocyte detection for cancer analysis using a novel fusion block based channel boosted CNN.
Autorzy:
Rauf Z; Pattern Recognition Lab, Department of Computer and Information Sciences, Pakistan Institute of Engineering and Applied Sciences, Nilore, 45650, Islamabad, Pakistan.; PIEAS Artificial Intelligence Center (PAIC), Pakistan Institute of Engineering and Applied Sciences, Nilore, 45650, Islamabad, Pakistan.
Khan AR; Pattern Recognition Lab, Department of Computer and Information Sciences, Pakistan Institute of Engineering and Applied Sciences, Nilore, 45650, Islamabad, Pakistan.
Sohail A; Pattern Recognition Lab, Department of Computer and Information Sciences, Pakistan Institute of Engineering and Applied Sciences, Nilore, 45650, Islamabad, Pakistan.; Department of Electrical Engineering and Computer Science, Khalifa University of Science and Technology, Abu Dhabi, UAE.
Alquhayz H; Department of Computer Science and Information, College of Science in Zulfi, Majmaah University, 11952, Al-Majmaah, Saudi Arabia.
Gwak J; Department of Software, Korea National University of Transportation, Chungju, 27469, Republic of Korea. .
Khan A; Pattern Recognition Lab, Department of Computer and Information Sciences, Pakistan Institute of Engineering and Applied Sciences, Nilore, 45650, Islamabad, Pakistan. .; PIEAS Artificial Intelligence Center (PAIC), Pakistan Institute of Engineering and Applied Sciences, Nilore, 45650, Islamabad, Pakistan. .; Center for Mathematical Sciences, Pakistan Institute of Engineering and Applied Sciences, Nilore, 45650, Islamabad, Pakistan. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Aug 28; Vol. 13 (1), pp. 14047. Date of Electronic Publication: 2023 Aug 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lymphocytes*
Neoplasms*/diagnosis
Humans ; Lymphocytes, Tumor-Infiltrating ; Artifacts ; Biology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Direct AKT activation in tumor-infiltrating lymphocytes markedly increases interferon-γ (IFN-γ) for the regression of tumors resistant to PD-1 checkpoint blockade.
Autorzy:
Santinon F; Département de Médecine, Université de Montréal, Montréal, QC, H3C 3J7, Canada.; Division of Immunology-Oncology, Centre de Recherche Hopital Maisonneuve-Rosemont, Montréal, QC, H1T 2M4, Canada.
Ezzahra BF; Division of Immunology-Oncology, Centre de Recherche Hopital Maisonneuve-Rosemont, Montréal, QC, H1T 2M4, Canada.
Bachais M; Département de Médecine, Université de Montréal, Montréal, QC, H3C 3J7, Canada.; Division of Immunology-Oncology, Centre de Recherche Hopital Maisonneuve-Rosemont, Montréal, QC, H1T 2M4, Canada.
Sarabia Pacis A; Canadian Centre for Computational Genomics, McGill University, Montréal, QC, H3A 0G1, Canada.
Rudd CE; Département de Médecine, Université de Montréal, Montréal, QC, H3C 3J7, Canada. .; Canadian Centre for Computational Genomics, McGill University, Montréal, QC, H3A 0G1, Canada. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Nov 02; Vol. 12 (1), pp. 18509. Date of Electronic Publication: 2022 Nov 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*
Neoplasms*/pathology
Humans ; Programmed Cell Death 1 Receptor/metabolism ; Interferon-gamma/metabolism ; Proto-Oncogene Proteins c-akt/metabolism ; CD8-Positive T-Lymphocytes
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
CD83 expression characterizes precursor exhausted T cell population.
Autorzy:
Wu Z; Division of Immune Response, Aichi Cancer Center Research Institute, Nagoya, Japan.
Yoshikawa T; Division of Immune Response, Aichi Cancer Center Research Institute, Nagoya, Japan.; Division of Tumor Immunology, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan.
Inoue S; Division of Immune Response, Aichi Cancer Center Research Institute, Nagoya, Japan.
Ito Y; Division of Immune Response, Aichi Cancer Center Research Institute, Nagoya, Japan.; Division of Tumor Immunology, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan.
Kasuya H; Division of Immune Response, Aichi Cancer Center Research Institute, Nagoya, Japan.
Nakashima T; Division of Immune Response, Aichi Cancer Center Research Institute, Nagoya, Japan.; Department of Hematology and Oncology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan.
Zhang H; Division of Immune Response, Aichi Cancer Center Research Institute, Nagoya, Japan.; Division of Cellular Oncology, Department of Cancer Diagnostics and Therapeutics, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Kotaka S; Department of Gynecologic Oncology, Aichi Cancer Center, Nagoya, Japan.
Hosoda W; Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan.
Suzuki S; Department of Gynecologic Oncology, Aichi Cancer Center, Nagoya, Japan.
Kagoya Y; Division of Immune Response, Aichi Cancer Center Research Institute, Nagoya, Japan. .; Division of Cellular Oncology, Department of Cancer Diagnostics and Therapeutics, Nagoya University Graduate School of Medicine, Nagoya, Japan. .; Division of Tumor Immunology, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan. .
Pokaż więcej
Źródło:
Communications biology [Commun Biol] 2023 Mar 11; Vol. 6 (1), pp. 258. Date of Electronic Publication: 2023 Mar 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
T-Lymphocyte Subsets*/metabolism
Neoplasms*
Humans ; Receptors, CCR7/metabolism ; Immunotherapy ; Lymphocytes, Tumor-Infiltrating
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Human FOXP3 and tumour microenvironment.
Autorzy:
Wang J; Center of Tumor Immunology and Cytotherapy, Medical Research Center, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.; Qingdao Medical School, Qingdao University, Qingdao, Shandong, China.
Gong R; Center of Tumor Immunology and Cytotherapy, Medical Research Center, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Zhao C; Center of Tumor Immunology and Cytotherapy, Medical Research Center, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Lei K; Center of Tumor Immunology and Cytotherapy, Medical Research Center, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
Sun X; Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, China.
Ren H; Center of Tumor Immunology and Cytotherapy, Medical Research Center, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.; Department of Pancreatic Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China.
Pokaż więcej
Źródło:
Immunology [Immunology] 2023 Feb; Vol. 168 (2), pp. 248-255. Date of Electronic Publication: 2022 Jul 06.
Typ publikacji:
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Forkhead Transcription Factors*/genetics
Neoplasms*/pathology
Humans ; Tumor Microenvironment ; Lymphocytes, Tumor-Infiltrating ; Prognosis ; T-Lymphocytes, Regulatory
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers.
Autorzy:
Lowery FJ; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Krishna S; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Yossef R; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Parikh NB; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Chatani PD; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Zacharakis N; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Parkhurst MR; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Levin N; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Sindiri S; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Sachs A; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Hitscherich KJ; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Yu Z; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Vale NR; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Lu YC; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Zheng Z; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Jia L; National Institutes of Health Library, National Institutes of Health, Bethesda, MD 20892, USA.
Gartner JJ; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Hill VK; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Copeland AR; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Nah SK; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Masi RV; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Gasmi B; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Kivitz S; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Paria BC; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Florentin M; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Kim SP; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Hanada KI; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Li YF; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Ngo LT; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Ray S; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Shindorf ML; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Levi ST; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Shepherd R; Vector Production Facility, Clinical Research Directorate, Frederick National Laboratory for Cancer Research, Bethesda, MD 20892, USA.
Toy C; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Parikh AY; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Prickett TD; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Kelly MC; Single Cell Analysis Facility, Cancer Research Technology Program, Frederick National Laboratory, Bethesda, MD 20892, USA.
Beyer R; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Goff SL; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Yang JC; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Robbins PF; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Rosenberg SA; Surgery Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2022 Feb 25; Vol. 375 (6583), pp. 877-884. Date of Electronic Publication: 2022 Feb 03.
Typ publikacji:
Journal Article; Research Support, N.I.H., Intramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Neoplasm Metastasis*
Transcriptome*
Antigens, Neoplasm/*immunology
Lymphocytes, Tumor-Infiltrating/*immunology
Neoplasms/*immunology
Receptors, Antigen, T-Cell/*immunology
T-Lymphocytes/*immunology
CD4-Positive T-Lymphocytes/immunology ; CD4-Positive T-Lymphocytes/metabolism ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/metabolism ; Gene Regulatory Networks ; Humans ; Lymphocytes, Tumor-Infiltrating/metabolism ; Neoplasms/genetics ; Neoplasms/metabolism ; RNA-Seq ; Single-Cell Analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
ProTICS reveals prognostic impact of tumor infiltrating immune cells in different molecular subtypes.
Autorzy:
Liu S; School of Computer Science, Northwestern Polytechnical University, Xi'an, 710129, Shaanxi, China.; Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, M5S 3E1, ON, Canada.; Department of Computer Science, University of Toronto, Toronto, M5S 2E4, ON, Canada.
Zhang Y; School of Computer Science, Northwestern Polytechnical University, Xi'an, 710129, Shaanxi, China.
Shang X; School of Computer Science, Northwestern Polytechnical University, Xi'an, 710129, Shaanxi, China.
Zhang Z; Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, M5S 3E1, ON, Canada.; Department of Computer Science, University of Toronto, Toronto, M5S 2E4, ON, Canada.; Department of Molecular Genetics, University of Toronto, Toronto, M5S 1A8, ON, Canada.
Pokaż więcej
Źródło:
Briefings in bioinformatics [Brief Bioinform] 2021 Nov 05; Vol. 22 (6).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Biomarkers, Tumor*
Tumor Microenvironment*/genetics
Tumor Microenvironment*/immunology
Computational Biology/*methods
Lymphocytes, Tumor-Infiltrating/*immunology
Lymphocytes, Tumor-Infiltrating/*metabolism
Neoplasms/*etiology
Neoplasms/*mortality
Algorithms ; Databases, Genetic ; Gene Expression Profiling/methods ; Humans ; Immunophenotyping ; Lymphocytes, Tumor-Infiltrating/pathology ; Neoplasms/diagnosis ; Prognosis ; Proportional Hazards Models
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pan-cancer single-cell landscape of tumor-infiltrating T cells.
Autorzy:
Zheng L; Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China.
Qin S; BIOPIC, Beijing Advanced Innovation Center for Genomics, School of Life Sciences, Peking University, Beijing 100871, China.
Si W; Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China.
Wang A; Gastrointestinal Cancer Center, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing 100142, China.
Xing B; Department of Hepatopancreatobiliary Surgery I, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing 100142, China.
Gao R; BIOPIC, Beijing Advanced Innovation Center for Genomics, School of Life Sciences, Peking University, Beijing 100871, China.
Ren X; BIOPIC, Beijing Advanced Innovation Center for Genomics, School of Life Sciences, Peking University, Beijing 100871, China.
Wang L; BIOPIC, Beijing Advanced Innovation Center for Genomics, School of Life Sciences, Peking University, Beijing 100871, China.
Wu X; Gastrointestinal Cancer Center, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing 100142, China.
Zhang J; Gastrointestinal Cancer Center, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing 100142, China.
Wu N; Department of Thoracic Surgery II, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing 100142, China.
Zhang N; Department of Urology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing 100142, China.
Zheng H; Department of Gynecologic Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing 100142, China.
Ouyang H; Department of Orthopaedics, Peking University Third Hospital, Beijing 100191, China.; Beijing Key Laboratory of Spinal Disease Research, Peking University Third Hospital, Beijing 100191, China.
Chen K; Department of Orthopaedics, Peking University Third Hospital, Beijing 100191, China.; Beijing Key Laboratory of Spinal Disease Research, Peking University Third Hospital, Beijing 100191, China.
Bu Z; Gastrointestinal Cancer Center, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing 100142, China.
Hu X; BIOPIC, Beijing Advanced Innovation Center for Genomics, School of Life Sciences, Peking University, Beijing 100871, China.; Analytical Biosciences Limited, Beijing 100084, China.
Ji J; Gastrointestinal Cancer Center, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing 100142, China.; Department of Biobank, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital and Institute, Beijing 100142, China.
Zhang Z; Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China.; BIOPIC, Beijing Advanced Innovation Center for Genomics, School of Life Sciences, Peking University, Beijing 100871, China.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2021 Dec 17; Vol. 374 (6574), pp. abe6474. Date of Electronic Publication: 2021 Dec 17.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Transcriptome*
Lymphocytes, Tumor-Infiltrating/*physiology
Neoplasms/*immunology
T-Lymphocyte Subsets/*physiology
Tumor Microenvironment/*immunology
CD4-Positive T-Lymphocytes/immunology ; CD4-Positive T-Lymphocytes/physiology ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/physiology ; Cell Differentiation ; Gene Expression Regulation, Neoplastic ; Humans ; Lymphocytes, Tumor-Infiltrating/immunology ; Memory T Cells/immunology ; Memory T Cells/physiology ; Neoplasms/genetics ; RNA-Seq ; Receptors, Antigen, T-Cell/genetics ; Receptors, Antigen, T-Cell/metabolism ; Single-Cell Analysis ; T-Lymphocyte Subsets/immunology ; Transcription Factors/genetics ; Transcription Factors/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Intratumor heterogeneity: the hidden barrier to immunotherapy against MSI tumors from the perspective of IFN-γ signaling and tumor-infiltrating lymphocytes.
Autorzy:
Wu W; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China, 410008.; Key Laboratory for Molecular Radiation Oncology of Hunan Province, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China, 410008.
Liu Y; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China, 410008.; Key Laboratory for Molecular Radiation Oncology of Hunan Province, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China, 410008.
Zeng S; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China, 410008. .; Key Laboratory for Molecular Radiation Oncology of Hunan Province, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China, 410008. .; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, People's Republic of China. .
Han Y; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China, 410008. .; Key Laboratory for Molecular Radiation Oncology of Hunan Province, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China, 410008. .; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, People's Republic of China. .
Shen H; Department of Oncology, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China, 410008. .; Key Laboratory for Molecular Radiation Oncology of Hunan Province, Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China, 410008. .; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, People's Republic of China. .
Pokaż więcej
Źródło:
Journal of hematology & oncology [J Hematol Oncol] 2021 Oct 07; Vol. 14 (1), pp. 160. Date of Electronic Publication: 2021 Oct 07.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Microsatellite Instability*
Immunotherapy/*methods
Interferon-gamma/*immunology
Lymphocytes, Tumor-Infiltrating/*immunology
Neoplasms/*therapy
Animals ; Humans ; Interferon-gamma/genetics ; Lymphocytes, Tumor-Infiltrating/metabolism ; Lymphocytes, Tumor-Infiltrating/pathology ; Neoplasms/genetics ; Neoplasms/immunology ; Neoplasms/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A Systematic Review and Meta-Analysis on the Significance of TIGIT in Solid Cancers: Dual TIGIT/PD-1 Blockade to Overcome Immune-Resistance in Solid Cancers.
Autorzy:
Hosseinkhani N; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz 5165665811, Iran.
Shadbad MA; Research Center for Evidence-Based Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz 5166614766, Iran.
Asghari Jafarabadi M; Department of Statistics and Epidemiology, School of Medicine, Zanjan University of Medical Sciences, Zanjan 4513956184, Iran.; Center for the Development of Interdisciplinary Research in Islamic Sciences and Health Sciences, Tabriz University of Medical Sciences, Tabriz 4513956184, Iran.
Karim Ahangar N; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz 5165665811, Iran.
Asadzadeh Z; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz 5165665811, Iran.
Mohammadi SM; Department of Anatomical Sciences, School of Medicine, Zanjan University of Medical Sciences, Zanjan 4513956184, Iran.
Lotfinejad P; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz 5165665811, Iran.
Alizadeh N; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz 5165665811, Iran.
Brunetti O; Medical Oncology Unit, IRCCS Istituto Tumori 'Giovanni Paolo II' of Bari, 70124 Bari, Italy.
Fasano R; Medical Oncology Unit, IRCCS Istituto Tumori 'Giovanni Paolo II' of Bari, 70124 Bari, Italy.
Silvestris N; Medical Oncology Unit, IRCCS Istituto Tumori 'Giovanni Paolo II' of Bari, 70124 Bari, Italy.; Department of Biomedical Sciences and Human Oncology (DIMO), University of Bari, 70124 Bari, Italy.
Baradaran B; Research Center for Evidence-Based Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz 5166614766, Iran.; Department of Immunology, Tabriz University of Medical Sciences, Tabriz 5165665811, Iran.; Pharmaceutical Analysis Research Center, Tabriz University of Medical Sciences, Tabriz 5166614766, Iran.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2021 Sep 27; Vol. 22 (19). Date of Electronic Publication: 2021 Sep 27.
Typ publikacji:
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:
Tumor Escape*
CD8-Positive T-Lymphocytes/*immunology
Lymphocytes, Tumor-Infiltrating/*immunology
Neoplasm Proteins/*immunology
Neoplasms/*immunology
Programmed Cell Death 1 Receptor/*immunology
Receptors, Immunologic/*immunology
CD8-Positive T-Lymphocytes/pathology ; Gene Expression Regulation, Neoplastic/immunology ; Humans ; Immunotherapy ; Lymphocytes, Tumor-Infiltrating/pathology ; Neoplasms/pathology ; Neoplasms/therapy
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors.
Autorzy:
Wang S; Clinical Cancer Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Sun J; Grit Biotechnology Ltd., Shanghai, China.
Chen K; NHC Key Laboratory of Pulmonary Immunological Diseases, Guizhou Provincial People's Hospital, Guiyang, China.
Ma P; Clinical Cancer Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Lei Q; Clinical Cancer Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Xing S; Clinical Cancer Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Cao Z; Grit Biotechnology Ltd., Shanghai, China.
Sun S; Queen Mary School, Nanchang University, Nanchang, 330006, China.
Yu Z; Geneplus-Shenzhen, Shenzhen, China.
Liu Y; Grit Biotechnology Ltd., Shanghai, China. .
Li N; Clinical Cancer Center, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. .
Pokaż więcej
Źródło:
BMC medicine [BMC Med] 2021 Jun 11; Vol. 19 (1), pp. 140. Date of Electronic Publication: 2021 Jun 11.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Lymphocytes, Tumor-Infiltrating*
Neoplasms*/therapy
Humans ; Immunotherapy, Adoptive ; Lymphocytes
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Lymphocytes in tumor-draining lymph nodes co-cultured with autologous tumor cells for adoptive cell therapy.
Autorzy:
Okamura K; Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan. .
Nagayama S; Department of Gastroenterological and Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan.
Tate T; Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Chan HT; Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Kiyotani K; Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Nakamura Y; Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
Pokaż więcej
Źródło:
Journal of translational medicine [J Transl Med] 2022 May 23; Vol. 20 (1), pp. 241. Date of Electronic Publication: 2022 May 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
CD8-Positive T-Lymphocytes*
Neoplasms*/pathology
Neoplasms*/therapy
Cell- and Tissue-Based Therapy ; Coculture Techniques ; Humans ; Immunotherapy, Adoptive ; Lymph Nodes/pathology ; Lymphocytes ; Lymphocytes, Tumor-Infiltrating ; Receptors, Antigen, T-Cell
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
BIRC5 is a prognostic biomarker associated with tumor immune cell infiltration.
Autorzy:
Xu L; Department of Hepato-Biliary-Pancreatic Surgery, Jiujiang First People's Hospital, Jiujiang, 332000, China.
Yu W; Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, 330006, China.
Xiao H; Hepato-Biliary-Pancreatic Surgery Division, Department of General Surgery, The Second Affiliated Hospital of Nanchang University, No.1, Minde Road, Nanchang, 330006, China. .
Lin K; Gastrointestinal Surgery Division, Department of General Surgery, The Second Affiliated Hospital of Nanchang University, No.1, Minde Road, Nanchang, 330006, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Jan 11; Vol. 11 (1), pp. 390. Date of Electronic Publication: 2021 Jan 11.
Typ publikacji:
Journal Article
MeSH Terms:
Neoplasms*/diagnosis
Neoplasms*/genetics
Neoplasms*/immunology
Neoplasms*/mortality
Lymphocytes, Tumor-Infiltrating/*physiology
Survivin/*physiology
Biomarkers, Tumor/genetics ; Case-Control Studies ; Cell Proliferation/genetics ; Datasets as Topic ; Gene Expression Regulation, Neoplastic ; Humans ; Lymphocytes, Tumor-Infiltrating/metabolism ; Prognosis ; Survival Analysis ; Survivin/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The roles of CC chemokines in response to radiation.
Autorzy:
Wang L; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, People's Republic of China.
Jiang J; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, People's Republic of China. .
Chen Y; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, People's Republic of China.
Jia Q; Chongqing Key Laboratory of Immunotherapy, Chongqing, People's Republic of China.; Department of Oncology, Xinqiao Hospital, Third Military Medical University, Chongqing, People's Republic of China.
Chu Q; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, 430030, People's Republic of China.
Pokaż więcej
Źródło:
Radiation oncology (London, England) [Radiat Oncol] 2022 Apr 01; Vol. 17 (1), pp. 63. Date of Electronic Publication: 2022 Apr 01.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Epithelial-Mesenchymal Transition*
Neoplasms*/pathology
Humans ; Immunotherapy ; Lymphocytes, Tumor-Infiltrating ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Tumor-Mediated Neutrophil Polarization and Therapeutic Implications.
Autorzy:
Raftopoulou S; Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, 8010 Graz, Austria.
Valadez-Cosmes P; Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, 8010 Graz, Austria.
Mihalic ZN; Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, 8010 Graz, Austria.
Schicho R; Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, 8010 Graz, Austria.
Kargl J; Division of Pharmacology, Otto Loewi Research Center, Medical University of Graz, 8010 Graz, Austria.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Mar 16; Vol. 23 (6). Date of Electronic Publication: 2022 Mar 16.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Neoplasms*/pathology
Neutrophils*
Humans ; Immunotherapy ; Lymphocytes, Tumor-Infiltrating/pathology ; Tumor Microenvironment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Molecular correlates and therapeutic targets in T cell-inflamed versus non-T cell-inflamed tumors across cancer types.
Autorzy:
Bao R; Hillman Cancer Center, UPMC, Pittsburgh, PA, 15232, USA.; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, 15232, USA.
Stapor D; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, 15232, USA.
Luke JJ; Hillman Cancer Center, UPMC, Pittsburgh, PA, 15232, USA. .; Department of Medicine, University of Pittsburgh, Pittsburgh, PA, 15232, USA. .
Pokaż więcej
Źródło:
Genome medicine [Genome Med] 2020 Oct 27; Vol. 12 (1), pp. 90. Date of Electronic Publication: 2020 Oct 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Biomarkers, Tumor*
Lymphocytes, Tumor-Infiltrating/*immunology
Lymphocytes, Tumor-Infiltrating/*metabolism
Neoplasms/*etiology
T-Lymphocytes/*immunology
T-Lymphocytes/*metabolism
Databases, Genetic ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Genes, Tumor Suppressor ; Humans ; Lymphocytes, Tumor-Infiltrating/pathology ; Molecular Targeted Therapy ; Mutation ; Neoplasms/metabolism ; Neoplasms/pathology ; Neoplasms/therapy ; Oncogenes ; Organ Specificity/genetics ; Signal Transduction ; Tumor Escape/genetics ; Tumor Microenvironment/genetics ; Tumor Microenvironment/immunology ; Whole Genome Sequencing
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Immunologic Effects of Stereotactic Body Radiotherapy in Dogs with Spontaneous Tumors and the Impact of Intratumoral OX40/TLR Agonist Immunotherapy.
Autorzy:
Boss MK; Department of Environmental Health and Radiological Sciences, Colorado State University, Fort Collins, CO 80523, USA.
Watts R; Department of Companion Animals, Atlantic Veterinary College, Charlottetown, PE C1A 4P3, Canada.
Harrison LG; Department of Environmental Health and Radiological Sciences, Colorado State University, Fort Collins, CO 80523, USA.
Hopkins S; Department of Clinical Sciences, Colorado State University, Fort Collins, CO 80523, USA.
Chow L; Department of Clinical Sciences, Colorado State University, Fort Collins, CO 80523, USA.
Trageser E; Department of Environmental Health and Radiological Sciences, Colorado State University, Fort Collins, CO 80523, USA.
Easton C; Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO 80523, USA.
LaRue SM; Department of Environmental Health and Radiological Sciences, Colorado State University, Fort Collins, CO 80523, USA.
Regan D; Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, CO 80523, USA.
Dewhirst MW; Department of Radiation Oncology, Duke University Medical Center, Durham, NC 27710, USA.
Dow S; Department of Clinical Sciences, Colorado State University, Fort Collins, CO 80523, USA.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2022 Jan 13; Vol. 23 (2). Date of Electronic Publication: 2022 Jan 13.
Typ publikacji:
Journal Article
MeSH Terms:
Antineoplastic Agents, Immunological/*pharmacology
Dog Diseases/*therapy
Neoplasms/*veterinary
Radiosurgery/*methods
Receptors, OX40/*antagonists & inhibitors
Toll-Like Receptors/*antagonists & inhibitors
Animals ; Combined Modality Therapy ; Cytokines ; Dog Diseases/diagnosis ; Dog Diseases/etiology ; Dogs ; Female ; Gene Expression ; Lymphocytes, Tumor-Infiltrating/immunology ; Lymphocytes, Tumor-Infiltrating/metabolism ; Lymphocytes, Tumor-Infiltrating/pathology ; Male ; Neovascularization, Pathologic/metabolism ; Radiotherapy, Image-Guided ; Tomography, X-Ray Computed ; Treatment Outcome ; Tumor Microenvironment/immunology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Remodeling of the tumor microenvironment via disrupting Blimp1 effector Treg activity augments response to anti-PD-1 blockade.
Autorzy:
Dixon ML; Department of Neurosurgery, University of Alabama at Birmingham, 1600 6th Avenue South, CHB 118A, Birmingham, AL, 35233, USA.; Graduate Biomedical Sciences Program, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Luo L; Department of Neurosurgery, University of Alabama at Birmingham, 1600 6th Avenue South, CHB 118A, Birmingham, AL, 35233, USA.; School of Pharmacy, Nantong University, Nantong, Jiangsu, 226001, China.
Ghosh S; Department of Neurosurgery, University of Alabama at Birmingham, 1600 6th Avenue South, CHB 118A, Birmingham, AL, 35233, USA.; The O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Grimes JM; Department of Neurosurgery, University of Alabama at Birmingham, 1600 6th Avenue South, CHB 118A, Birmingham, AL, 35233, USA.; Graduate Biomedical Sciences Program, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Leavenworth JD; Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA.
Leavenworth JW; Department of Neurosurgery, University of Alabama at Birmingham, 1600 6th Avenue South, CHB 118A, Birmingham, AL, 35233, USA. .; The O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, 35294, USA. .; Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, 35294, USA. .
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2021 Nov 20; Vol. 20 (1), pp. 150. Date of Electronic Publication: 2021 Nov 20.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
MeSH Terms:
Neoplasms/*etiology
Neoplasms/*metabolism
Positive Regulatory Domain I-Binding Factor 1/*metabolism
T-Lymphocytes, Regulatory/*immunology
T-Lymphocytes, Regulatory/*metabolism
Tumor Microenvironment/*genetics
Tumor Microenvironment/*immunology
Animals ; Cell Line, Tumor ; Disease Models, Animal ; Fluorescent Antibody Technique ; Forkhead Transcription Factors/genetics ; Forkhead Transcription Factors/metabolism ; Humans ; Immune Checkpoint Inhibitors/pharmacology ; Immune Checkpoint Inhibitors/therapeutic use ; Immunity, Humoral/genetics ; Immunomodulation/drug effects ; Immunophenotyping ; Lymphocytes, Tumor-Infiltrating/drug effects ; Lymphocytes, Tumor-Infiltrating/immunology ; Lymphocytes, Tumor-Infiltrating/metabolism ; Macrophages/immunology ; Macrophages/metabolism ; Melanoma, Experimental ; Mice ; Mice, Knockout ; Neoplasms/drug therapy ; Neoplasms/pathology ; Positive Regulatory Domain I-Binding Factor 1/genetics ; Programmed Cell Death 1 Receptor/antagonists & inhibitors ; T-Lymphocytes, Regulatory/drug effects ; Transcriptome ; Treatment Outcome ; Tumor Microenvironment/drug effects
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
A Pan-Cancer Analysis of Clinical Prognosis and Immune Infiltration of CKS1B in Human Tumors.
Autorzy:
Jia Y; Department of Hematology, Xiangya Hospital, Central South University, Changsha, China.
Tian Q; Department of Reproductive Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China.
Yang K; Department of Hematology, Xiangya Hospital, Central South University, Changsha, China.
Liu Y; Department of Hematology, Xiangya Hospital, Central South University, Changsha, China.
Liu Y; Department of Hematology, Xiangya Hospital, Central South University, Changsha, China.
Pokaż więcej
Źródło:
BioMed research international [Biomed Res Int] 2021 Nov 20; Vol. 2021, pp. 5862941. Date of Electronic Publication: 2021 Nov 20 (Print Publication: 2021).
Typ publikacji:
Journal Article
MeSH Terms:
Oncogenes*
Biomarkers, Tumor/*genetics
Biomarkers, Tumor/*immunology
CDC2-CDC28 Kinases/*genetics
CDC2-CDC28 Kinases/*immunology
Neoplasms/*genetics
Neoplasms/*immunology
CDC2-CDC28 Kinases/chemistry ; Cancer-Associated Fibroblasts/immunology ; Cancer-Associated Fibroblasts/pathology ; DNA Methylation ; Disease Progression ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Lymphocytes, Tumor-Infiltrating/immunology ; Lymphocytes, Tumor-Infiltrating/pathology ; Male ; Microsatellite Instability ; Mutation ; Neoplasms/pathology ; Prognosis ; Protein Conformation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Systematic Pan-Cancer Analysis of KLRB1 with Prognostic Value and Immunological Activity across Human Tumors.
Autorzy:
Cheng X; Department of Integrated Traditional Chinese & Western Medicine, The Second Xiangya Hospital, Central South University, Changsha, China.
Cao Y; The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510006, China.
Wang X; Department of Pathology, The Second Xiangya Hospital, Central South University, Changsha, China.
Cheng L; Department of Integrated Traditional Chinese & Western Medicine, The Second Xiangya Hospital, Central South University, Changsha, China.
Liu Y; Regenerative Medicine Institute (REMEDI), National University of Ireland Galway, University Road, Galway, Ireland H91 TK33.
Lei J; Department of Integrated Traditional Chinese & Western Medicine, The Second Xiangya Hospital, Central South University, Changsha, China.
Peng W; Department of Integrated Traditional Chinese & Western Medicine, The Second Xiangya Hospital, Central South University, Changsha, China.
Shi D; Department of Gynecology and Obstetrics, Xiangya Hospital, Central South University, Changsha, Hunan 410008, China.
Pokaż więcej
Źródło:
Journal of immunology research [J Immunol Res] 2022 Jan 03; Vol. 2022, pp. 5254911. Date of Electronic Publication: 2022 Jan 03 (Print Publication: 2022).
Typ publikacji:
Journal Article
MeSH Terms:
Immunotherapy/*methods
Neoplasms/*pathology
Biomarkers, Tumor/metabolism ; Gene Expression Profiling ; Humans ; Killer Cells, Natural/metabolism ; Lymphocytes, Tumor-Infiltrating/immunology ; Mutation ; NK Cell Lectin-Like Receptor Subfamily B ; Prognosis ; Systematic Reviews as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Characterization of tumour-infiltrating lymphocytes in a tumour rejection cynomolgus macaque model.
Autorzy:
Satooka H; Department of Fundamental Biosciences, Shiga University of Medical Science, Otsu, Japan.
Ishigaki H; Department of Pathology, Shiga University of Medical Science, Otsu, Japan.
Todo K; Department of Fundamental Biosciences, Shiga University of Medical Science, Otsu, Japan.
Terada K; Department of Biochemistry and Molecular Biology, Shiga University of Medical Science, Otsu, Japan.
Agata Y; Department of Biochemistry and Molecular Biology, Shiga University of Medical Science, Otsu, Japan.
Itoh Y; Department of Pathology, Shiga University of Medical Science, Otsu, Japan.
Ogasawara K; Department of Pathology, Shiga University of Medical Science, Otsu, Japan.
Hirata T; Department of Fundamental Biosciences, Shiga University of Medical Science, Otsu, Japan. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2020 May 21; Vol. 10 (1), pp. 8414. Date of Electronic Publication: 2020 May 21.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
CD4-Positive T-Lymphocytes/*immunology
CD8-Positive T-Lymphocytes/*immunology
Immunotherapy, Adoptive/*methods
Lymphocytes, Tumor-Infiltrating/*immunology
Neoplasms/*immunology
Animals ; Antigens, CD/metabolism ; Antigens, Differentiation, T-Lymphocyte/metabolism ; CD4-Positive T-Lymphocytes/transplantation ; CD8-Positive T-Lymphocytes/transplantation ; CX3C Chemokine Receptor 1/metabolism ; Cell Line, Tumor ; Chemokine CXCL10/metabolism ; Chemokine CXCL11/metabolism ; Chemokine CXCL9/metabolism ; Lectins, C-Type/metabolism ; Lymphocytes, Tumor-Infiltrating/transplantation ; Macaca fascicularis ; Models, Animal ; Neoplasms/therapy ; Receptors, CXCR3/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 141

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies